Raphael Pharmaceutical increases authorized common shares to 50M (from 21M)

Raphael Pharmaceutical Inc.

Authorized common shares increased from 21,020,560 to 50,000,000 effective June 26, 2024.
Board approved the increase on May 9, 2024; majority shareholders approved on May 22, 2024.
Company filed Amended and Restated Articles of Incorporation with Nevada Secretary of State.

item 5.03 item 9.01

Raphael Pharmaceutical Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-056191

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.